> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CBER Ups Likely 2022 Guidances
- URL: https://www.fdaweb.com/cber-ups-likely-2022-guidances/
- Published: 2022-05-10T12:00:00.000Z
- Updated: 2026-09-14T17:44:07.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5151777

CBER has updated its calendar year 2022 guidance agenda to list 17 guidances the Center is considering for development this year. The revised [agenda](https://www.fda.gov/media/120341/download?ref=fdaweb.com) lists eight topics under Blood and Blood Components, seven topics under Tissues and Advanced Therapies, and two topics under Vaccines. The previous [agenda](https://www.fdaweb.com/cber-plans-13-guidances-in-2022/) projected 13 guidances, with six under Blood and Blood Components, six under Tissues and Advanced Therapies, and one under Vaccines.